Gemstone Biotherapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 9

Gemstone Biotherapeutics General Information

Description

Developer of scar free skin regeneration technology designed to address unmet medical needs in dermatology, plastic surgery and burn care. The company's platform offer products that accelerate healing, avoid complex closure and regenerate skin without scarring after burns or excisions, enabling patients to heal wounds.

Contact Information

Formerly Known As
Chiron Labs, Hydro3Labs, Gemstone Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 180 West Ostend Street
  • Suite 277A
  • Baltimore, MD 21230
  • United States
+1 (443) 000-0000

Gemstone Biotherapeutics Timeline

2017201820192020
Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemstone Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-Jan-2019 00.000 Completed Generating Revenue
4. Grant 22-Jun-2018 00000 00.000 Completed Generating Revenue
3. Early Stage VC 27-Oct-2016 00000 00.000 Completed Generating Revenue
2. Early Stage VC 08-Jun-2015 $1.6M $2.45M Completed Generating Revenue
1. Accelerator/Incubator 05-Feb-2015 $850K $850K Completed Generating Revenue
To view Gemstone Biotherapeutics’s complete valuation and funding history, request access »

Gemstone Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of scar free skin regeneration technology designed to address unmet medical needs in dermatology, plastic surg
Biotechnology
Baltimore, MD
00.000
000000000000 00.000

000000 0

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
0000000000000
Jerusalem, Israel
00 As of 0000
00000
00000000 00000

0000000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000000
Mont-Saint-Guibert, Belgium
0 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gemstone Biotherapeutics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gamida Cell Formerly VC-backed Jerusalem, Israel 00 00000 00000000 00000
0000000 Venture Capital-Backed Mont-Saint-Guibert, Belgium 0 000.00 00000000000 000.00
000 000000000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed New York, NY 00 000.00 000000000 000.00
000000000000 00000 Venture Capital-Backed Jerusalem, Israel 00 000.00 000000000000 000.00
To view Gemstone Biotherapeutics’s complete competitors history, request access »

Gemstone Biotherapeutics Executive Team (4)

Name Title Board Seat Contact Info
Eric Clarke Chief Financial Officer
Sharon Gerecht Ph.D Co-Founder
To view Gemstone Biotherapeutics’s complete executive team members history, request access »

Gemstone Biotherapeutics Board Members (4)

Name Representing Role Since
David Oros Gemstone Biotherapeutics Board Member 000 0000
Geoff MacKay Gemstone Biotherapeutics Board Member 000 0000
Xin Huang Gemstone Biotherapeutics Board Member 000 0000
To view Gemstone Biotherapeutics’s complete board members history, request access »

Gemstone Biotherapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
America's Seed Fund Government 000 0000 000000 0
Maryland Stem Cell Research Fund Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »